Objective: To investigate whether there is an association between serum thyroid-stimulating hormone (TSH) within the normal range and body mass index (BMI). Design and subjects: The study was performed in 6164 subjects (2813 males) who attended the fifth Tromsø study in 2001, and in 1867 subjects (873 males) that attended both the fourth Tromsø study in 1994/1995 as well as the fifth Tromsø study. Measurements: Height, weight, and serum TSH were measured in all subjects, and smoking status was recorded. Results: Smokers and nonsmokers were analyzed separately. In the fifth Tromsø study, serum TSH was positively and significantly associated with BMI in the nonsmokers. Within the normal TSH range (defined as the 2.5-97.5 percentile), nonsmoking males in the highest TSH quartile had a mean BMI 0.4 kg/m 2 higher compared to those in the lower quartile, whereas the difference for nonsmoking women was 1.4 kg/m 2 . Similarly, in nonsmokers in the longitudinal study, there was a significant and positive association between delta serum TSH (serum TSH in 2001 minus serum TSH in 1994) and delta BMI in those with serum TSH within the normal range both in 1994 and 2001. In these subjects, the quartile with the highest delta serum TSH had a mean increase in BMI from 1994 to 2001 that was 0.3 kg/m 2 higher compared to those in the quartile with the lowest delta serum TSH. For the smokers, relations between serum TSH and BMI were not statistically significant. Conclusion: In nonsmokers there is a positive association between serum TSH within the normal range and BMI.
Introduction
Overt hyperthyroidism is well known to be associated with weight loss 1 and, correspondingly, hypothyroidism with weight gain. 2 However, little is known about weight changes within the normal range of thyroid function. Although there are several large epidemiological studies on thyroid function, [3] [4] [5] none has paid particular attention to the relation between thyroid function and weight. In recent years there has been an increasing focus on subclinical thyroid dysfunction, which may have impact on morbidity as well as mortality. Thus, subclinical hyperthyroidism, defined as a combination of low serum thyroidstimulating hormone (TSH) but with free thyroxine levels within the reference range, is a risk factor for atrial fibrillation. 6, 7 Similarly, subclinical hypothyroidism, defined as an elevated serum TSH but with serum free thyroxine levels within the normal range, is associated with dyslipidemia, 8 and is a risk factor for ischemic heart disease and allcause mortality. 9, 10 In spite of this, there is considerable disagreement regarding when to start treatment, in particular for subclinical hypothyroidism. 11, 12 In this respect, the relation between thyroid function and weight might also be of importance, as overweight is associated with increased morbidity and disability. 13 In order to address this issue, we have analyzed data from the Tromsø studies, which are general health surveys arranged for the first time in 1974. At the fourth Tromsø study in 1994-1995 and the fifth in 2001, serum TSH was measured in 3570 and 7954 subjects, respectively. A considerable number of subjects participated on both occasions, which gave us the opportunity to evaluate the relation between serum TSH and body mass index (BMI) both cross-sectionally as well as longitudinally.
Methods
In the fourth Tromsø study 1994-1995 (for simplicity 1994 in the following), all men and women aged 424 years who were living in the municipality of Tromsø, which is the major city in northern Norway, were invited to participate. A subgroup was invited to a second phase that included blood samples for hormone analysis. In the fifth Tromsø study in  2001, all men and women older than 29 years, living in the  same area, and who participated in the second phase of the  fourth Tromsø study or became 30, 40, 45, 60, or 75 years old  during 2001 , were invited to participate. On both occasions a questionnaire including use of thyroid hormones and smoking status was filled in. Those who smoked daily were classified as smokers, the others as nonsmokers. Height and weight were measured while the subjects wore light clothing and no shoes. BMI was calculated as weight divided by squared height. Blood samples were drawn in the nonfasting state. Serum samples from the fourth Tromsø study in 1994 were analyzed for TSH in 2001, whereas samples from the fifth Tromsø study were analyzed within 12 months. All samples were stored frozen at À701C and analyzed with the AxSYM instrument (Abbott, IL, USA). In our laboratory, the reference range for serum TSH is 0.20-4.00 mIU/l.
Statistical analyses
Normal distribution was evaluated with visual inspection of histograms and determination of skewness and kurtosis, and all variables used as dependent variables were considered normally distributed.
To test for main effects and interactions in the fifth Tromsø study, a factor analysis was performed using a general linear model with BMI as dependent variable, serum TSH quartiles, smoking status, and gender as factors, and age as an independent variable. In this model there were significant effects of gender and smoking status regarding BMI, as well as a significant interaction between the two. Analyses from the fifth Tromsø study were therefore performed sex-specific and separately for smokers and nonsmokers.
Similarly, for the analyses on changes from 1994 to 2001, a factor analysis was used with delta BMI (BMI from 2001 minus BMI from 1994) as dependent variable, delta serum TSH (TSH from 2001 minus TSH from 1994) quartile, gender, and smoking status as factors, and age in 1994 and BMI in 1994 as covariables. In this model smoking status was a significant factor, whereas gender was not. Further analyses were therefore carried out in smokers and nonsmokers separately, but males and females together. Those who had changed smoking status from 1994 to 2001 were excluded.
Linear trends across serum TSH quartiles and delta serum TSH quartiles were tested with linear regression with the use of covariables as described in the tables. Analysis of covariance was used to calculate adjusted means of BMI by age. For testing the cross-sectional relation between serum TSH and BMI in the fifth Tromsø study, and the predictive effect of delta serum TSH on delta BMI, linear regression models were used with covariables as appears from the tables.
The main analyses from the fifth Tromsø study were carried out on those with serum TSH within the 2.5-97.5 percentile range. The main analyses on changes from 1994 to 2001 were carried out on those with serum TSH in 1994 within the 2.5-97.5 percentile range (0.48-4.27 mIU/l) and who in 2001 also had serum TSH within the 2.5-97.5 percentile range (0.52-4.63 mIU/l). In addition, the effects of serum TSH and delta serum TSH, used as continuous variables, on BMI and delta BMI were also analyzed in all subjects together without limitations regarding the serum TSH level.
Comparison between those with serum TSH in the lower (o2.5 percentile) and upper (497.5 percentile) TSH ranges versus those with serum TSH in the normal range (2.5-97.5 percentile) were performed with linear regression with age as a covariable.
Unless otherwise stated, all data are expressed as mean7s.d. All tests were carried out two-sided, and Po0.05 was considered statistically significant. Statistical analyses were performed with SPSS version 12.0 (SPSS Inc., Chicago, IL, USA).
Ethics
The study was approved by the regional ethics committee. All subjects gave their written informed consent.
Results
The fifth Tromsø study A total of 10 419 men and women, aged 29-89, were invited to the fifth Tromsø study and 8128 persons attended. Serum TSH was successfully measured in 7954. We excluded present (n ¼ 521) and previous (n ¼ 49) thyroxine users, and those with missing data on thyroid medication (n ¼ 1220). This left us with a final study group of 6164 persons, 2813 males and 3351 females, of whom 736 and 911 were smokers, respectively (Table 1) .
There was a gradual increase in serum TSH with age in both males and females, nonsmokers and smokers. In males there was an increase in BMI up to the age group 50-59 years and thereafter a decline, whereas in females the BMI's in the age groups 450 years were almost identical ( Table 2 ).
In the nonsmokers there was a gradual increase in BMI, with increasing TSH quartile within the normal range (2.5-97.5 percentile) in both males and females. For females this was statistically significant (Po0.01, linear trend), but not for the males (P ¼ 0.054). The difference in age-adjusted BMI between the highest and lowest serum TSH quartiles in the nonsmoking females was 0.9 kg/m 2 . In the smokers, no statistically significant relation between serum TSH and BMI was found (Table 3) .
In the nonsmoking females, those with serum TSH below the 2.5 percentile had significantly lower mean BMI than those with TSH between the 2.5 and 97. In the multiple linear regression model with serum TSH as a continuous variable (and age as a covariable), serum TSH within the normal range was positively and significantly associated with BMI in both nonsmoking males and nonsmoking females (Table 4) . To further evaluate the affect of age on the relation between TSH and BMI, a similar linear When all nonsmoking subjects were included regardless of TSH value, TSH was no longer a significant predictor of BMI, nor was TSH a significant predictor for BMI in the smokers (Table 4) .
Change in BMI versus change in TSH
In total, 27 180 subjects participated in the fourth Tromsø study. Among them, 3570 subjects had serum TSH measured, of whom 2672 had serum TSH measured in the fifth Tromsø study as well. Among these, 582 subjects were or had been using thyroxine, or data on thyroxine use were missing. Among the remaining 2090 subjects, 63 started smoking and 160 stopped smoking during the observation period, leaving 1867 subjects with unchanged smoking status. Of these subjects, 107 had serum TSH in 1994 outside the 2.5-97.5 percentile range, and 35 subjects had serum TSH outside the 2.5-97.5 percentile range in 2001. Thus, 1725 subjects were left for analysis on association between delta serum TSH and delta BMI within the 'normal TSH range'. Characteristics of these subjects are given in Table 1 .
There was in nonsmokers with serum TSH within the 2.5-97.5 percentile range in both 1994 and 2001 a nonsignificant increase in delta BMI with increasing delta TSH quartile (P ¼ 0.054). The difference in delta BMI (adjusted for age and BMI from 1994) between the upper and lower delta TSH quartiles was 0.31 kg/m 2 (Table 5) . However, when used as a continuous variable delta, TSH was significantly associated with delta BMI, both in the 'normal cohort' as well as when all subjects, regardless of TSH values in 1994 and 2001, were analyzed together (Table 6) . No statistical significant relations between delta BMI and delta serum TSH were seen in the smokers. The data on change in BMI versus change in TSH were analyzed for males and females together. However, if performed sex-specifically, the same trends were seen in both genders, but did not reach statistical significance.
Discussion
In the present study, we have found serum TSH within the normal range to be significantly and positively associated with BMI in nonsmoking men and women. Furthermore, TSH and BMI A Nyrnes et al during a 7 years follow-up period, we found that an increase in serum TSH was associated with an increase in BMI in nonsmokers.
Even if the associations between serum TSH and BMI were seen both in the cross-sectional as well as the longitudinal study, this does not necessarily imply a causal relation. TSH and BMI could both be affected by a third factor, and our observations merely reflect a covariation between serum TSH and BMI. In particular, there was an increase in both age and BMI with increasing TSH. To control for the effect of age, age was included as an independent variable in the multiple regression analysis. Furthermore, the association between TSH and BMI was also seen in those above the age of 49. In these subjects the BMI was falling with age in the males and almost unaffected by age in the females, and, accordingly, age is therefore an unlikely explanation for the association between TSH and BMI.
On the other hand, there are arguments for a causal relationship between TSH and BMI. Thus, our observations are in accordance with the general assumption of an association between thyroid function, weight, and adipose tissue. Hypothyroidism is associated with a decrease in metabolic rate 14, 15 and affects both lipid and carbohydrate metabolism. 16 There are receptors expressed for TSH as well as thyroid hormones in adipose tissue. 17 Thyroid hormones are involved in both lipogenesis and lipolysis, 18 an effect that possibly is mediated by affecting local noradrenaline levels and/or adrenergic postreceptor signalling. 19 Conversely, the synthesis of TSH and thyroid hormones may be affected by adipose tissue and caloric intake. Thus, in a study by Sari et al. on 98 obese women who over a 6 month period lost more than 10% of body weight, there was a significant decrease in TSH. 20 A similar observation was made by Rosenbaum et al., provided those who lost weight initially were obese. 21 The mechanism for such a relation, if it exists, is not known, but could possibly be related to the secretion of leptin by the adipose tissue. 22 The level of leptin is directly correlated to the amount of adipose tissue, and leptin has been reported to stimulate the biosynthesis of TSH in vitro.
23
Furthermore, there is a synchronicity between the secretion of leptin and TSH both in children 24 and in adults. 25 However, it must be emphasized that this putative relation between TSH and leptin is not supported by all studies. 26, 27 We only found the relation between TSH and BMI in nonsmokers. A similar but weaker trend was seen in the smokers, but the results were not statistically significant. This can partly be explained by the lower number of smokers than nonsmokers in the study, which gave the study less statistical power in that group. Furthermore, it is well known that smoking affects thyroid function, 28 which was exemplified in subjects who started/quitted smoking during the 7 years between the two Tromsø studies. Thus, those who started smoking had an increase in delta TSH of only 0.0770.8 versus 0.3270.9 mIU/l in those who stopped smoking (Po0.05, Student's t-test). Smoking also has a profound effect on BMI. 29 In the initial factor analysis, smoking was the strongest predictor for BMI in our study, and in the smokers the differences in BMI between age groups were less pronounced than in nonsmokers. It is therefore conceivable that smoking also could mask a relation between TSH and BMI. To test this, we looked separately at the relation between TSH and BMI in data from 1994 and in data from 2001 in those quitting and those starting smoking during the observation period. However, the numbers were too small to yield meaningful results (data not shown).
The mean weight gain in the whole group during the 7 years in the longitudinal study was 2.8 kg. In comparison, the difference in weight gain between the quartile that had the largest increase in serum TSH versus the quartile that had the lowest increase in TSH was 0.8 kg. Accordingly, if the increase in BMI is causally related to thyroid function, this relation might be of clinical importance, even within the normal TSH range.
The strength of our study is the large number of subjects studied, and the careful correction for age, gender and smoking status. However, our study has some major weaknesses. Firstly, free thyroxine and triiodothyronine were not measured, which could have added further information on the subjects' thyroid status. Secondly, our subjects belonged to the general population. Although we excluded those on TSH and BMI A Nyrnes et al thyroid medication, we probably included a number of subjects with thyroid dysfunction. Furthermore, concomitant drug consumption and nonthyroidal illness could affect both the serum TSH levels as well as the BMI in the study group. Thirdly, we evaluated BMI in relation to TSH, whereas it might have been more appropriate to evaluate, or at least include, measurement of the lean body mass. Lean body mass appears to a major determinant of thyroxine requirement, 30 and, if increased, might require increased TSH stimulation of the thyroid gland to maintain normal serum thyroxine levels.
In conclusion, we have found a positive and significant association between serum TSH within the normal range and BMI, both in a cross-sectional and a longitudinal study. However, this does not necessarily imply a causal relationship between thyroid function and BMI within the normal serum TSH range.
